Janux Therapeutics JANX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Janux Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's operating margin?
- Janux Therapeutics (JANX) reported operating margin of -1,143.1% in Q1 2026.
- How has Janux Therapeutics's operating margin changed year-over-year?
- Janux Therapeutics's operating margin increased by 6.0% year-over-year, from -1,216.6% to -1,143.1%.
- What is the long-term trend for Janux Therapeutics's operating margin?
- Over 4 years (2021 to 2025), Janux Therapeutics's operating margin has grown at a 14.9% compound annual growth rate (CAGR), from -905.4% to -1,576.7%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.